The Centers for Disease Control and Prevention today issued updated recommendations for managing and reporting Shigella infections that were treated with ciprofloxacin or azithromycin and resulted in possible clinical treatment failure. “If treatment failure is suspected, clinicians should consider consulting an infectious disease specialist to identify best treatment options, and submit a stool specimen for antimicrobial susceptibility testing,” CDC said. “Clinicians should monitor patients carefully and report cases of possible clinical treatment failure to CDC.” Shigella bacteria can cause Shigellosis, a diarrheal disease that should be reported to local health departments. 

Related News Articles

Headline
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…
Headline
The National Institutes of Health May 8 released an analysis that found incidences of 14 types of cancer increased among people under age 50 from 2010-2019.…
Headline
A New England Journal of Medicine study published yesterday found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer…
Headline
Overall cancer death rates declined steadily among both men and women from 2018 through 2022, according to the National Institutes of Health's latest annual…